{"nct_id":"NCT02616783","title":"Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Adults Aged ≥ 60 Years","status":"COMPLETED","status_verified_date":"2019-01","start_date":"2015-12-22","start_date_type":"ACTUAL","primary_completion_date":"2018-02-21","primary_completion_date_type":"ACTUAL","completion_date":"2018-03-21","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GILD"]}